METHODS FOR TREATING ERECTILE DYSFUNCTION WITH A CGMP-SPECIFIC PHOSPHODIESTERASE 5 INHIBITOR PHARMACEUTICAL COMPOSITION

• 收藏
• 分享

专利权人:

AstraZeneca UK Limited

发明人:

Richard L. Skelly,Judy Firor

申请号：

US16440811

公开号：

US20190385719A1

申请日:

2019.06.13

申请国别(地区):

US

年份:

2019

代理人:

摘要：

A method is provided for treating erectile dysfunction in a subject in need thereof by administering a cGMP-specific phosphodiesterase 5 (PDE5) inhibitor pharmaceutical composition to a subject qualified for over-the-counter access to the PDE5 inhibitor pharmaceutical composition. In some embodiments, the PDE5 inhibitor pharmaceutical composition includes tadalafil or vardenafil.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/